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Infants and toddlers with suspected iron-
deficiency anemia (IDA) should begin treat-
ment with oral ferrous sulfate (3 mg/kg/d of
elemental iron). A rise in hemoglobin >1
g/dL after 4 weeks supports the diagnosis
of iron deficiency, and supplementation
should continue for 2 additional months to
replenish iron stores. Recheck hemoglobin
at the end of treatment and again 6 months
later (strength of recommendation [SOR]: C,
based on expert opinion).
For primary prevention, counsel parents
on the use of iron-fortified formula for non-
breastfed infants until the age 12 months
(SOR: B, based on randomized controlled
study), and introduce iron-rich foods
between 4 and 6 months to breastfed
babies (SOR: C, based on expert opinion).
If you need reassurance, check CBC 
and reticulocytes 1 week after start 
of iron therapy
While the evidence supports the empiric
approach, hemoglobin <11 g/dL has only a
29% positive predictive value for IDA. To
obtain quick reassurance the diagnosis is
correct, the pediatric faculty of our residen-
cy program advocates checking a complete
blood count and a reticulocyte count 1
week after beginning iron therapy. By then,
if the hemoglobin level stays the same or
shows a small increase and the reticulocyte
level is elevated, the diagnosis is confirmed.
When advising parents on how much iron
to give their child, remember that 3 mg of
elemental iron is contained in 15 mg of 
ferrous sulfate. The common over-the-
counter liquid ferrous sulfate product 
contains 15 mg of elemental iron per 0.6-mL
dropper. Thus, a 10-kg child would require 
a 0.6-mL dropper twice a day.
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z Evidence summary
Depletion of iron stores leads to IDA,
which, among children, is associated with
motor and cognitive deficits that may be
irreversible. Little is known about whether
iron deficiency, in the absence of anemia,
results in physiologic sequelae. A
Cochrane review of iron therapy for chil-
dren with IDA aged >3 years found no
short-term (5–11 days) improvement in
Bayley scores of mental and motor devel-
opment following iron therapy.1 A 10-year
longitudinal cohort study in Costa Rica
found that adolescents treated for severe
chronic IDA in infancy (n=48) scored 0.4
to 0.7 standard deviations lower on cogni-
tive and motor testing relative to controls
(n=114).2 In an Indonesian randomized
controlled trial (RCT), baseline Bayley
scores were 10% to 15% lower (P<.01) for
infants (12–18 months) with IDA com-
pared with both nonanemic iron-deficient
and iron-sufficient infants.3 Following
treatment with ferrous sulfate (3 mg/kg/d
of elemental iron) for 4 months, the IDA
infants’ Bayley scores improved compared
with those of nonanemic children.
Consensus recommendations suggest
that iron deficiency should be the presump-
tive diagnosis in a child with anemia, and
that a trial of ferrous sulfate at a dose of 3
mg/kg/d of elemental iron be instituted
because of low cost, tolerability, and rela-
tive simplicity.4,5 In a prospective study of
75 1-year-olds with anemia (hemoglobin
<11.0 g/dL), 45% achieved an increase in
hemoglobin ≥1 g/dL after 3 months of iron
therapy (3 mg/kg/d).6 An RCT of 278
nonanemic 1-year-olds found no difference
in adverse effects from this dose compared
with placebo.7 However, an analysis of data
from NHANES III showed that a Hgb
<11.0 had a positive predictive value of just
29% and sensitivity of 30% for diagnosing
iron-deficiency in children aged <3 years.8
The recommended dose of 3 mg/kg/d
was derived from models of bioavailability
and iron needs9; no studies compare alter-
native doses. An RCT of 557 anemic 
children under 24 months of age in Ghana
demonstrated that ferrous sulfate (5
mg/kg/d) given once daily was equivalent
to 3-times-daily dosing in terms of effec-
tiveness (61% vs 56%) and tolerance.10
Less frequent dosing has been studied in
developing countries with mixed results.
Because anemia may lead to develop-
mental impairment, primary prevention is
critical. In a cohort study, infants given
iron-fortified formula (n=98) were less
likely to become iron-deficient by their 12-
month visit than infants fed whole cow
milk (n=69) (11.2% vs 24.6%, number
needed to treat [NNT]=8).11 In a RCT of
inner-city children who had been switched
to cows’ milk by 6 months, half (n=50)
were randomized to receive iron-fortified
formula for another year, resulting in a
decreased risk of anemia at 24 months
(0% vs 26%, NNT=4), and smaller
declines in developmental functioning
compared with those on cows’ milk.12
Recommendations from others
The CDC and the Institute of Medicine rec-
ommend parental dietary counseling, treat-
ment with oral ferrous sulfate at 3 mg/kg/d
for 3 months to restore iron stores, and
monitoring of hemoglobin or hematocrit to
assess response.4,5 To prevent IDA, the
American Academy of Pediatrics (AAP)
recommends that all infants who are not
breastfed or are partially breastfed should
receive an iron-fortified formula (contain-
ing between 4.0–12 mg/L of iron) from
birth to 12 months. The AAP also recom-
mends that parents should refrain from
feeding cow’s milk to infants until after age
12 months and introduce iron-enriched
foods between ages 4 and 6 months.13
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Iron deficiency
should be the 
presumptive 
diagnosis in a
child with anemia;
give elemental iron
because of its low
cost and tolerability
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